Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.

This study compares a new version of a long-acting aripiprazole injection to the approved version (Abilify Maintena) in 116 adults with stable schizophrenia. Participants receive five injections over 141 days to see if the new version works the same in the body. The goal is to co…

This study tests an experimental injection called SYH2070 in 18 adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. The main goal is to see how much the drug lowers LDL (bad) cholesterol. Participants must alre…

This study tests a new medicine called SYH2053, given as a shot under the skin, for people with high cholesterol or mixed high blood fats who are already on cholesterol-lowering drugs like statins. The goal is to see if it can further lower their LDL (bad) cholesterol safely. Abo…

This study tests an injection called SYH2053 in 135 adults with heterozygous familial hypercholesterolemia (HeFH), an inherited condition causing very high cholesterol and heart disease risk. Participants must already be on a stable statin and low-fat diet. The main goal is to se…

This early-phase study tests the safety of a new drug called SYH2061 in 40 healthy adults aged 18 to 55. Participants receive either a single dose of the drug or a placebo, and researchers monitor for side effects and measure drug levels in the blood. The goal is to gather initia…